Europe Next Generation Sequencing Market 2025 By Product, Service, Application, & End User, and Country

The Europe next generation sequencing market is expected to reach US$ 7,685.4 Mn in 2025 from US$ 1,633.4 Mn in 2017. The market is estimated to grow with a CAGR of 21.4% from 2018-2025.

The growth of the market is driven by the factors such as, technological advancements in sequencing and development in genomics. However, the market is likely to get impacted due to nonexistence of skilled professionals and high risks associated with genetic data in next generation sequencing in the region.

Advancement in the field of molecular biology has equally enhanced the sequencing procedures. Many industry players have come up with innovative NGS technology in last few years. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms. The technological advancement as headed emergence of the New Bioeconomy, which is the replacement of petrochemical-based manufacturing and fermentation-based manufacturing products. For instance, in October 2018, Roche launched three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumors, complement Roche’s NGS ctDNA kits for oncology research. Additionally, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX, Illumina HiSeq 2000 and AB SOLiD.

NGS makes sequence based gene expression analysis a “digital” alternative to analog techniques. It also aids in quantifying RNA expression with the breadth of a microarray and the resolution of qPCR. Advancement in genome sequencing have added various solution for most of the industries such as, pharmaceutical and agriculture. These technological advancement are likely to grow the market in near future. Thus, technological advancements are expected to bring about innovative treatments in the market thereby driving the Europe next generation sequencing market growth over the forecast years.

Germany is expected to lead the market in the Europe region owing to increasing funds and growing number of cancer patients in the country. Moreover, increasing focus of on R&D is helps to drive the market growth in the forecast period. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

Rest of Europe Next Generation Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)

EUROPE NEXT GENERATION SEQUENCING - MARKET SEGMENTATION

By Product

• Consumables

• Services

• Platforms

By Technology

• Genome Sequencing

• Exome Sequencing

• Resequencing & Targeted Sequencing

• Other

By Application

• Diagnostics

• Drug Discovery

• Precision Medicine

• Others

By End User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinics

• Others

By Geography

• Europe

• UK

• Germany

• France

Company Profiles

• Illumina, Inc.

• Thermo Fisher

• Qiagen N.V.,

• Beijing Genomics Institute

• PerkinElmer, Inc.

• F.Hoffman-La Roche Ltd.

• Agilent Technologies

• Eurofins Scientific

• Oxford Nanopore Technologies Ltd.

• Macrogen Inc.

Europe Next Generation Sequencing Strategic Insights

Strategic insights for the Europe Next Generation Sequencing provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-next-generation-sequencing-market-strategic-framework.webp

Get more information on this report

Europe Next Generation Sequencing Report Scope

Report Attribute	Details
Market size in 2017	US$ 1,633.4 Million
Market Size by 2025	US$ 7,685.4 Million
Global CAGR (2018 - 2025)	21.4%
Historical Data	2015-2016
Forecast period	2018-2025
Segments Covered	By Product Platforms Services Consumables By Service Genome Sequencing Exome Sequencing Resequencing Targeted Sequencing & Other Sequencing Technologies By Application Diagnostics Drug Discovery Precision Medicine & Other Applications By End User Academic & Research Institutes Pharmaceutical & Biotechnology Companies Hospitals Clinics & Other End Users
Regions and Countries Covered	Europe UK Germany France Russia Italy Rest of Europe
Market leaders and key company profiles	Illumina, Inc. Thermo Fisher Qiagen N.V., Beijing Genomics Institute PerkinElmer, Inc. F.Hoffman-La Roche Ltd. Agilent Technologies Eurofins Scientific Oxford Nanopore Technologies Ltd. Macrogen Inc.

Get more information on this report

Europe Next Generation Sequencing Regional Insights

The geographic scope of the Europe Next Generation Sequencing refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.